| Literature DB >> 32374280 |
Abstract
In view of the role of pharmacotherapy in medicine, on the one hand, and the powerful technical possibilities that are now available on the other hand, therapeutic drug monitoring is a surprisingly neglected area of laboratory medicine. In this viewpoint article, an "omics approach" to pharmacovigilance and drug monitoring is proposed and discussed. A realistic goal for laboratory medicine in the 21st century should indeed be to enable clinicians to check whether the right drug is present in the right patient with an appropriate blood concentration for each compound.Entities:
Keywords: drug-omics; immunoassay; individualization; mass spectrometry; pharmacokinetics; therapeutic drug monitoring
Year: 2020 PMID: 32374280 DOI: 10.1515/cclm-2020-0339
Source DB: PubMed Journal: Clin Chem Lab Med ISSN: 1434-6621 Impact factor: 3.694